These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 25216840

  • 1. Role of pre-Xpert® screening using chest X-ray in early diagnosis of smear-negative pulmonary tuberculosis.
    Somashekar N, Chadha VK, Praseeja P, Sharada MA, Chandrakala GR, Srivastava R, Kumar P, Japananda S.
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1243-4. PubMed ID: 25216840
    [Abstract] [Full Text] [Related]

  • 2. Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda.
    Wekesa C, Kirenga BJ, Joloba ML, Bwanga F, Katamba A, Kamya MR.
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):216-9. PubMed ID: 24429316
    [Abstract] [Full Text] [Related]

  • 3. The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
    Ananthakrishnan R, Thiagesan R, Auguesteen S, Karunakaran N, Jayabal L, M J, Stevens R, Codlin A, Creswell J.
    PLoS One; 2020 Feb; 15(11):e0241203. PubMed ID: 33147240
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
    Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D, AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams.
    Clin Infect Dis; 2016 May 01; 62(9):1081-8. PubMed ID: 26839383
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
    Khalil KF, Butt T.
    J Coll Physicians Surg Pak; 2015 Feb 01; 25(2):115-8. PubMed ID: 25703755
    [Abstract] [Full Text] [Related]

  • 6. Are registered sputum smear-negative tuberculosis patients in Karnataka, India, diagnosed by national algorithm?
    Chadha VK, Praseeja P, Hemanthkumar NK, Shivshankara BA, Sharada MA, Nagendra N, Padmesh R, Puttuswamy G, Ahmed J, Kumar P.
    Int J Tuberc Lung Dis; 2014 Dec 01; 18(12):1491-5. PubMed ID: 25517817
    [Abstract] [Full Text] [Related]

  • 7. Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert® MTB/RIF?
    Mok Y, Tan TY, Tay TR, Wong HS, Tiew PY, Kam JW, Siao C.
    Int J Tuberc Lung Dis; 2016 May 01; 20(5):619-24. PubMed ID: 27084815
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K.
    Am J Respir Crit Care Med; 2011 Jul 01; 184(1):132-40. PubMed ID: 21493734
    [Abstract] [Full Text] [Related]

  • 9. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E, Zablockis R, Nikolayevskyy V, Danila E, Davidaviciene E.
    Respir Med; 2015 Nov 01; 109(11):1484-9. PubMed ID: 26403251
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
    Walusimbi S, Semitala F, Bwanga F, Haile M, De Costa A, Davis L, Joloba M, Hoffner S, Kamya M.
    Pan Afr Med J; 2016 Nov 01; 23():154. PubMed ID: 27303572
    [Abstract] [Full Text] [Related]

  • 11. The reliability of a rapid molecular detection method in determining the prevalence of rifampicin-resistant Mycobacterium tuberculosis in an urban district health facility in Malaysia.
    Ding CH, Ismail Z, Sulong A, Wahab AA, Gan B, Mustakim S, Ahmad HF.
    Malays J Pathol; 2020 Dec 01; 42(3):401-407. PubMed ID: 33361721
    [Abstract] [Full Text] [Related]

  • 12. Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.
    Muyoyeta M, Moyo M, Kasese N, Ndhlovu M, Milimo D, Mwanza W, Kapata N, Schaap A, Godfrey Faussett P, Ayles H.
    PLoS One; 2015 Dec 01; 10(6):e0126376. PubMed ID: 26030301
    [Abstract] [Full Text] [Related]

  • 13. Predictors of smear-negative pulmonary tuberculosis in HIV-infected patients, Battambang, Cambodia.
    Tamhane A, Chheng P, Dobbs T, Mak S, Sar B, Kimerling ME.
    Int J Tuberc Lung Dis; 2009 Mar 01; 13(3):347-54. PubMed ID: 19275795
    [Abstract] [Full Text] [Related]

  • 14. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL, Theron G, Khalfey H, Peter J, Meldau R, Matinyenya B, Davids M, Smith L, Pooran A, Lesosky M, Esmail A, Miller MG, Piercy J, Michell L, Dawson R, Raine RI, Joubert I, Dheda K.
    Lancet Respir Med; 2015 Aug 01; 3(8):621-30. PubMed ID: 26208996
    [Abstract] [Full Text] [Related]

  • 15. Chest X ray score (Timika score): an useful adjunct to predict treatment outcome in tuberculosis.
    Chakraborthy A, Shivananjaiah AJ, Ramaswamy S, Chikkavenkatappa N.
    Adv Respir Med; 2018 Aug 01; 86(5):205-210. PubMed ID: 30378646
    [Abstract] [Full Text] [Related]

  • 16. Pooling sputum from multiple individuals for Xpert® MTB/RIF testing: a strategy for screening high-risk populations.
    Zishiri V, Chihota V, McCarthy K, Charalambous S, Churchyard GJ, Hoffmann CJ.
    Int J Tuberc Lung Dis; 2015 Jan 01; 19(1):87-90. PubMed ID: 25519796
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH, Aslan MH, Aşık G.
    Mikrobiyol Bul; 2011 Jan 01; 45(1):43-7. PubMed ID: 21341158
    [Abstract] [Full Text] [Related]

  • 18. The sensitivity and specificity of using a computer aided diagnosis program for automatically scoring chest X-rays of presumptive TB patients compared with Xpert MTB/RIF in Lusaka Zambia.
    Muyoyeta M, Maduskar P, Moyo M, Kasese N, Milimo D, Spooner R, Kapata N, Hogeweg L, van Ginneken B, Ayles H.
    PLoS One; 2014 Jan 01; 9(4):e93757. PubMed ID: 24705629
    [Abstract] [Full Text] [Related]

  • 19. Routine use of Xpert® MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.
    Page AL, Ardizzoni E, Lassovsky M, Kirubi B, Bichkova D, Pedrotta A, Lastrucci C, de la Tour R, Bonnet M, Varaine F.
    Int J Tuberc Lung Dis; 2015 Sep 01; 19(9):1078-83, i-iii. PubMed ID: 26260829
    [Abstract] [Full Text] [Related]

  • 20. Xpert(®) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children.
    Singh M, Sethi GR, Mantan M, Khanna A, Hanif M.
    Int J Tuberc Lung Dis; 2016 Jun 01; 20(6):839-43. PubMed ID: 27155190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.